Aliénor Vienne-Jumeau has a total of 83 co-authors. Here are the top co-authors by number of shared publications:

  • Sarah Mrejen

    Centre Hospitalier National d'Ophtalmologie des quinze-vingts, Paris, France

    5 shared publications
  • Antoine Pierre Brézin

    Université Paris Cité, Centre d'ophtalmologie de l'Assistance Publique, Hôpitaux de Paris, Paris, France

    4 shared publications
  • Dominique Monnet

    Ophtalmopôle, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France

    3 shared publications
  • Elodie Bousquet

    Department of Ophthalmology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France

    3 shared publications
  • Matthieu P. Robert

    Department of Ophthalmology, Necker-Enfants Malades University Hospital, APHP, Paris, France

    3 shared publications
  • Michel Paques

    Centre Hospitalier National d'Ophtalmologie des quinze-vingts, Paris, France

    3 shared publications

Latest Publications

  • Open Access

    ACUTE BILATERAL RETINAL AND CHOROIDAL DETACHMENT—A CASE REPORT

    by Aliénor Vienne-Jumeau, Adélaïde Toutée, Samira Zegrari, Céline Jamart, Isabelle Audo, Michel Paques, Sarah Mrejen

    Purpose: To report an unusual episode of acute bilateral retinal and choroidal detachment. Methods: Case report. Results: We report the case of a 57-year-old man referred to the emergency department for an acute bilateral retinal detachment. He had experienced profound visual loss 3 weeks earlier while hospitalized for sepsis of unknown cause. Fundoscopy revealed bilateral annular retinal and choroidal detachment, confirmed by echography. An extensive workup was negative, and the patient was given steroid boluses for suspected uveal effusion syndrome, although the axial length was normal. After 5 days of steroid treatment, minimal improvement was observed. The treatment was discontinued, and new multimodal imaging revealed a hyperfluorescent spot on fluorescein angiography in the right eye with subretinal hyperreflective material on corresponding optical coherence tomography, suggesting fibrin and adjacent serous detachment. The spot was treated with laser photocoagulation, and the retinal detachment started to decrease 2 days later. Additional hyperfluorescent spots were later found and treated with laser photocoagulation. For a few weeks, both functional and anatomical improvements were observed. During the course of 7 months, the central serous retinal detachment slowly and completely resolved while vision progressively and dramatically improved. This very slow and dramatic anatomical and functional improvement was atypical for both uveal effusion syndrome and central serous chorioretinopathy. Conclusion: This atypical case of type-3 uveal effusion syndrome presented as acute bilateral retinal and choroidal detachment with central serous chorioretinopathy-like features. Multifocal laser photocoagulation may have improved both functional and anatomical outcomes, with dramatic recovery after 7 months.

  • Factors Associated With Single-Surgery Anatomical Success After Pars Plana Vitrectomy in Inferior Rhegmatogenous Retinal Detachment.

    by Amine Habib, Nour Boungab, Karine Lagrené, Maxime Wack, Sarah Ayello-Scheer, Francine Behar-Cohen, Pierre-Olivier Barale, Stéphane Bertin, Aliénor Vienne-Jumeau

    Purpose: To evaluate associations between retinopexy modality, surgical and anatomical factors, and single-surgery anatomical success (SSAS) after pars plana vitrectomy (PPV) for primary inferior rhegmatogenous retinal detachment (RRD). Methods: This retrospective single-center cohort included consecutive eyes undergoing PPV for primary inferior RRD with at least 3 months of follow-up. The primary outcome was SSAS, defined as absence of redetachment during follow-up and at least 2 months after silicone oil removal when applicable. Results: Among 235 eyes, median follow-up was 8 months. SSAS was achieved in 175 eyes (74.5%), while 60 eyes (25.5%) redetached at a median of 35 days. SSAS was 83.3% with endolaser, 74.6% with combined retinopexy, and 64.6% with cryotherapy (p = 0.021). In multivariable analysis, endolaser was associated with lower odds of failure compared with cryotherapy (OR 0.21, 95% CI 0.09–0.48; p = 0.00037), while combined retinopexy was associated with intermediate odds of failure (OR 0.39, 95% CI 0.15–0.95; p = 0.043). Compared with PVR grade A, grade B (OR 5.19, 95% CI 2.30–12.37; p = 0.00011) and grade C (OR 10.60, 95% CI 4.15–28.84; p < 0.00001) were associated with higher odds of anatomical failure. A causative break at 6 o’clock was also associated with higher odds of failure (OR 4.61; p = 0.005). Conclusion: In PPV for inferior RRD, endolaser retinopexy was associated with significantly higher anatomical success than cryotherapy, with combined treatment yielding intermediate outcomes. No significant association was observed between anatomical outcome and tamponade choice or PFCL use.

  • Open Access

    SPONTANEOUS RELEASE OF AN EPIRETINAL MEMBRANE IN AN ADULT PATIENT WITH STARGARDT DISEASE—A CASE REPORT

    by Aliénor Vienne-Jumeau, Raphael Atia, Isabelle Audo, Michel Paques, Sarah Mrejen

    Purpose: To report an unusual episode of formation and spontaneous release of a thickened hyaloid and dense epiretinal membrane (ERM) complicating Stargardt disease. Methods: Case report. Results: We report the case of a 40-year-old woman who was followed in our center with a diagnosis of Stargardt. She was lost to follow-up and returned to the clinic 7 years later with recent visual loss in her left eye. Fundus examination revealed a vitreomacular adhesion with a thickened hyaloid and dense tractional ERM that was not present at the last visit. Observation was decided and the ERM underwent a spontaneous separation from the underlying retina during follow-up. Conclusions: This is a case of spontaneous release of an ERM in a patient with a known diagnostic of Stargardt disease and ongoing posterior vitreous detachment. It supports that surgical abstention and observation may be a relevant alternative in eyes with an ERM complicating Stargardt disease.

  • Open Access

    A Dataset of Widefield Fundus Images From Patients With Birdshot Chorioretinitis and Matched Control

    by Thomas Foulonneau, Caroline Memmi, Dominique Monnet, Antoine P. Brézin, Aliénor Vienne-Jumeau

    Birdshot chorioretinitis is a rare uveitis where research is limited by the lack of large, publicly available imaging datasets. To address this gap, we present Birdshot-Wide, a standardized retinal imaging dataset comprising 5,042 widefield fundus photographs from 742 eyes with birdshot chorioretinitis (BSCR) and 1,310 images from 742 age-and sex- matched healthy eyes controls. The BSCR cohort is longitudinal, with a median follow-up of 4.31 years. Each image in the BSCR cohort was manually reviewed for quality and classified by dominant lesion subtype. To demonstrate its utility, the dataset was benchmarked on a classification task, where deep learning models trained to differentiate BSCR from control images achieved an area under the receiver operating characteristic curve of up to 0.96. This dataset, with its detailed metadata, provides a valuable resource for biomarker discovery, the development of automated diagnostic tools, and disease progression modeling.


  • Genetic, clinical, and biological risk factors associated with optic nerve thinning in sickle cell disease

    by Medhi Siab, Aliénor Vienne-Jumeau, Marc Romana, Chahine Belhadia, Erika Laurent, Maryse Etienne-Julan, Philippe Connes, Laurence Beral

    To determine whether adults with sickle cell disease (SCD) without glaucoma exhibit subclinical structural optic neuropathy (SON) on optical coherence tomography (OCT) and to identify genetic, clinical, and biologic correlates of optic nerve thinning. Monocentric, retrospective cross-sectional study of 185 eyes from 96 adults with SCD (116 eyes/59 HbSS; 69 eyes/37 HbSC) and 40 eyes from 20 controls. Spectral-domain OCT measured Bruch's membrane opening-minimum rim width (BMO-MRW), peripapillary retinal nerve fibre layer (RNFL), and macular ganglion cell complex (GCC). SON was defined as concordant thinning across all three parameters. Patient-clustered models with Holm adjustment compared groups; multivariable clustered logistic regression identified risk factors. Compared with controls, SCD eyes showed thinner BMO-MRW, RNFL, and GCC (all p < 0.001). Within SCD, HbSC exhibited greater thinning than HbSS, especially in temporal and superonasal BMO-MRW sectors and RNFL average, inferotemporal, and superotemporal sectors. Proliferative SCR showed more pronounced loss than non-proliferative disease, including lower BMO-MRW, temporal RNFL thinning, and global GCC reduction. Haemoglobin correlated positively with BMO-MRW in HbSS (ρ = 0.41, p = 0.001), haematocrit tended toward a negative association with RNFL in HbSC (ρ = -0.29, p = 0.06), and reticulocytes were inversely associated with GCC in HbSS (ρ = -0.25, p = 0.038) and HbSC (ρ = -0.31, p = 0.038). Older age, recent acute chest syndrome, and ≥1 vaso-occlusive crisis within 2 years independently increased SON odds, whereas higher haemoglobin was protective. Adults with SCD show OCT-detectable subclinical SON linked to genotype, retinopathy stage, anaemia severity, and vaso-occlusive burden; combined BMO-MRW, RNFL, and GCC may aid risk-stratified surveillance.

  • InertiaLocoGraphy for routine quantification of gait disorders in multiple sclerosis

    by Aliénor Vienne-Jumeau

    InertiaLocoGraphie pour la quantification en routine clinique des troubles de la marche chez les patients atteints de sclérose en plaques: Les troubles de la marche liés à une pathologie neurologique, musculosquelettique ou au vieillissement peuvent être responsables d’une diminution de la mobilité, d’une invalidité, d’une peur de tomber voire de chutes. Ils entravent sévèrement la qualité de vie et peuvent majorer le risque de décès. À ce jour, l’évaluation de la marche repose principalement sur l’évaluation visuelle du clinicien ou, à l’opposé, sur des dispositifs sophistiqués et coûteux. Les mesures dérivées de l’observation visuelle peuvent être biaisées, sujettes à un effet de plafond et manquer de sensibilité pour des changements minimes. Les systèmes d’analyse de la marche tels que CodaMotion® ou Vicon®, bien que très précis, ne peuvent cependant pas être utilisés dans le cadre de consultations de routine et sont déployés dans des laboratoires très spécialisés. Dans ce contexte, les unités de mesure inertielles (IMUs) offrent un compromis prometteur en termes de coût et d’ergonomie: ce sont des capteurs portables non invasifs, petits et légers, auxquels il est aisé de recourir en routine neurologique. La dégradation de la marche est notamment considérée par les patients atteints de sclérose en plaques (SEP) comme le symptôme le plus invalidant de leur maladie. Plus d’un patient atteint de SEP sur deux rapporte une chute dans une période de six mois. Les tests cliniques actuels permettent d’identifier des dégradations à un stade avancé, mais les IMUs pourraient être mis à profit pour détecter des modifications plus précoces ou plus légères, avant notamment qu’elles ne deviennent irréversibles. Cependant, en raison de la grande variabilité interindividuelle et des changements importants de ces troubles au cours de l’évolution de la maladie, plusieurs problèmes restent à surmonter. Ce travail vise à évaluer l’utilisation potentielle des IMUs pour la quantification de la locomotion en routine clinique - procédé que nous avons nommé InertiaLocoGraphie (ILG) - chez les patients atteints de sclérose en plaques (SEP). Premièrement, nous proposons une introduction à l’analyse de la marche, dressant un bref rappel historique et rappelant les principes fondamentaux de l’analyse de la marche. Dans la deuxième partie de cette thèse, nous nous inspirons d’études antérieures pour examiner les défis techniques et analytiques posés par l’ILG dans la pratique neurologique quotidienne afin d’élaborer un protocole d’analyse chez les patients atteints de SEP. Les parties suivantes de cette thèse traitent de trois approches analytiques complémentaires de l’ILG pour le suivi des patients atteints de SEP, approches faisant appel à des niveaux de traitement du signal de complexité croissante. Ainsi, la troisième partie se place sous l’angle de l’analyse du signal brut, s’appuyant sur la mise au point d’une méthode innovante de détection de patrons personnalisés de marche, pour comparer directement les signaux entre eux. Nous détaillons dans la quatrième partie, une étude des paramètres cinématiques de la locomotion. Enfin, dans la cinquième partie, est présenté un modèle biomécanique permettant d’extraire un biomarqueur cinétique du risque de chute et de la réponse au traitement chez des patients atteints d’une SEP. Dans l’ensemble, ces travaux constituent une avancée vers le développement d’une nouvelle famille de biomarqueurs, cohérents et accessibles en routine clinique, dérivés de l’analyse clinimétrique de la marche chez les patients atteints de SEP.

  • Open Access

    Pigment loss and pseudo-albinism in Birdshot chorioretinitis

    by Aliénor Vienne-Jumeau, Caroline Memmi, Souhila Kecili, Jordan Loeliger, Jennifer E. Thorne, Dominique Monnet, Antoine P. Brézin

    Objectives: To describe a rare phenotype of birdshot chorioretinitis (BSCR) characterised by diffuse retinal depigmentation and to evaluate its relationship with disease chronicity and visual outcomes. Methods: This observational study included patients from the CO-BIRD cohort with ultra-widefield fundus imaging. Retinal depigmentation was graded using the albinism scale by Kruijt et al. (grades 0–3). Eyes with a grade ≥ 2 in at least one image were included. Disease activity and severity were assessed using best-corrected visual acuity (BCVA), vision-related quality of life (VFQ-25), visual field testing and multimodal imaging. Results: Among 1016 eyes (508 patients), 52 eyes (26 patients, 5.1%) had depigmentation grade ≥ 2; 22 eyes (2.2%) reached grade 3. Fifteen years after symptom onset, BCVA worse than 0.7 logMAR occurred in 42.1% of grade 3 versus 5.0% of grade 2 eyes ( p = 0.014). VFQ-25 scores were similarly reduced in both groups. Grade 3 was associated with a lower risk of optic disc oedema (HR = 0.38; p = 0.028) and a non-significant reduction in macular oedema risk. Choroidal neovascularisation occurred only in grade 3 (40.9%). Grade 3 was linked to worse BCVA ( p = 0.012), higher pattern standard deviation ( p = 0.011), and a history of active disease. Compared with previously published CO-BIRD data, grade 3 showed faster BCVA decline ( p = 0.044) and greater cumulative loss ( p = 0.001). Conclusion: Diffuse retinal depigmentation resembling albinism is an uncommon but severe expression of BSCR, indicative of chronic disease and associated with poorer visual outcomes.